Discuss drugs used in treatment of epilepsy and indicate the main
molecular target of each - Also GABA-A receptor function What is epilepsy? • Group of neurological disorders characterized by recurrent seizures • Seizures come about due to episodic high-frequency discharge of impulses of groups of neurons in CNS • Different types: • Generalized • Convulsive • Tonic – rigidity • Clonic – jerks • Non-convulsive • Petit mal • Absence seizures • Loss of awareness • Partial • Focal seizures (one brain area) • Can spread to cause secondary seizures • Status epilepticus • Long persistent seizure (>5mins) • Can be fatal (no ventilation) Pathophysiology • Single/multiple mutations in channels which control neuronal activity • SCN1A and GABA • Can be caused by physical onslaught • Post-stroke • Head injury • Brian tumor • Often idiopathic Cause of Epilepsy • Epileptogenesis • Disruption in the balance of excitatory and inhibitory signals • Glutamate receptor agonists or GABA receptor antagonists/blockers can be used to trigger seizures • Loss of GABAergic neurons in cortex • Paroxysmal depolarising shift • Maintained change in resting membrane potential and threshold • Resembling prolonged glutamate release GABA-A receptors
• Expressed post and extra synaptically
• Large extracellular N-terminus, 4 transmembrane domains of which TM2 lines the pore • The loop (intracellular) between TM3 and TM4 is the site of modulation for this receptor • Permeable to chloride ions (resulting in hyperpolarisation) • GABA binds at alpha/beta interface (2 binding sites normally) GABA Pharmacology • Lorazepam and Diazepam – used to treat status epilepticus • Lead to tolerance, dependence and sedation (unsustainable) • Tiagabine • Inhibits GABA uptake (GAT1) • Increases extracellular concentration of GABA • Add-on for partial seizures • Vigabatrin • Irreversibly inhibits GABA transaminase (GAT) • Increase GABA concentration and release • Irreversibly therefore long lasting effect • Use in absence seizures and patients refractory to other treatment Sodium Channel Blockers • Lamotrigine • Use dependent blocker • May also block glutamate release • Carbamazepine • Use dependent blocker • Used in absence seizures • Bad side effects: Ataxia, hypersensitivity reaction • Metabolised by CYP450 so drug-drug interactions • Lacosamide • Enhances slow inactivation • In partial seizures • Phenytoin • Use dependent • Odd side effects: gum hyperplasia, excessive hair growth and ataxia Calcium channel modulators • Used for Absence seizures • Oscillations by 3Hz in EEG- Thalamocortical circuit 1. Activation of T type calcium channels in thalamocortical neurons 2. These neurons stimulate cortex and reticular thalamic nucleus- activate in bursts 3. GABA from the reticular thalamic nucleus inhibits the thalamocortical neurons which promotes the re-priming of T-type calcium channels 4. This activates thalamocortical neurons again • Ethosuximide • Absence seizure treatment only • May cause mood changes • Gabapentin • Binds alpha2-delta1 accessory subunit • Decreases Cav channel membrane expression • Also effective in partial seizures • Sodium valproate • Inhibits Nav channels and GABA transaminase • Use in generalised and partial seizures • May cause curling or thinning of the hair Miscellaneous • Zonisamide • Blocks Nav, Cav and may enhance GABA-A • Add-on therapy in generalized seizures • Topiramate • Blocks Cav, Nav, AMPA receptor and enhances GABA-A • Used for partial/generalised seizures • Retigabine • Kcnq2 channel opener • Whites of eyes turned blue • No longer used • Levetiracetam • SV2A binds (synaptic vesicle protein) • Affects synaptic vesicle docking – less transmitter released • Used for partial/generalised seizures Teratogenic risk • All antiepileptic drugs have teratogenic risk • Teratogens are drugs, chemicals, or even infections that can cause abnormal foetal development • Valproate for example can’t be prescribed to fertile women without contraception ads it carries such severe risks of birth defects and long-term effects on cognitive development
• Some antiepileptic drugs which induce hepatic
CYP3A4 enzymes may be increasing oral contraceptive metabolism and hence promote vitamin K deficiency in the newborn